CN113197993A - Traditional Chinese medicine composition for treating scrofula - Google Patents

Traditional Chinese medicine composition for treating scrofula Download PDF

Info

Publication number
CN113197993A
CN113197993A CN202110628752.2A CN202110628752A CN113197993A CN 113197993 A CN113197993 A CN 113197993A CN 202110628752 A CN202110628752 A CN 202110628752A CN 113197993 A CN113197993 A CN 113197993A
Authority
CN
China
Prior art keywords
parts
traditional chinese
chinese medicine
medicine composition
scrofula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202110628752.2A
Other languages
Chinese (zh)
Inventor
朱培于
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN202110628752.2A priority Critical patent/CN113197993A/en
Publication of CN113197993A publication Critical patent/CN113197993A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/55—Glands not provided for in groups A61K35/22 - A61K35/545, e.g. thyroids, parathyroids or pineal glands
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/902—Sparganiaceae (Bur-reed family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention relates to the technical field of traditional Chinese medicines, and in particular relates to a traditional Chinese medicine composition for treating scrofula. The traditional Chinese medicine composition for treating scrofula comprises the following components in parts by weight: 5-10 parts of Yuan cun; 5-10 parts of rhizoma sparganii; 10-15 parts of curcuma zedoary; 4-9 parts of dragon's blood; 10-15 parts of goose feathers. The traditional Chinese medicine composition for treating scrofula provided by the invention does not generate any toxic or side effect on a human body, is safe and effective, is prepared by selecting multiple medicinal materials for combination, and generates a synergistic effect on the effects of the medicinal materials, so that the scrofula can be effectively treated, and in addition, the breast cancer, lobular hyperplasia of mammary glands, ovarian abscess and cervical lymphoid tuberculosis can be effectively treated.

Description

Traditional Chinese medicine composition for treating scrofula
Technical Field
The invention relates to the technical field of traditional Chinese medicines, and in particular relates to a traditional Chinese medicine composition for treating scrofula.
Background
At present, scrofula, also called scrofula, is an infectious surgical disease originated from the neck, and the masses of different sizes of the nodule can be connected in series between the skin and the flesh of the neck, wherein the small one is called scrofula and the large one is called scrofula, and is mostly caused by specific infection caused by tubercle bacillus invading the neck. According to the traditional Chinese medicine, scrofula is caused by accumulation of wind-heat and qi-toxin in the triple energizer, liver, gallbladder and the like, and is divided into acute and chronic types due to deficiency of qi and blood and internal stirring of deficient fire in liver and kidney. Acute diseases are caused by affection of exogenous wind-heat and phlegm-toxin; chronic diseases are caused by qi stagnation and deficiency; since western medicines have great side effects in the treatment of scrofula, people have great needs for traditional Chinese medicines for effectively treating scrofula.
Disclosure of Invention
Aiming at the defects in the prior art, the traditional Chinese medicine composition for treating scrofula provided by the invention solves the technical problems and provides a traditional Chinese medicine composition capable of effectively treating scrofula.
In order to achieve the purpose, the invention provides the following technical scheme:
a traditional Chinese medicine composition for treating scrofula comprises the following components in parts by weight: 5-10 parts of Yuan cun; 5-10 parts of rhizoma sparganii; 10-15 parts of curcuma zedoary; 4-9 parts of dragon's blood; 10-15 parts of goose feathers.
A traditional Chinese medicine composition for treating scrofula comprises the following components in parts by weight: 5 parts of Yuan cun; 10 parts of rhizoma sparganii; 10 parts of curcuma zedoary; 4 parts of dragon's blood; 10 parts of goose feathers.
A traditional Chinese medicine composition for treating scrofula comprises the following components in parts by weight: 10 portions of Yuancun; 10 parts of rhizoma sparganii; 15 parts of curcuma zedoary; 4 parts of dragon's blood; 15 parts of goose feathers.
A traditional Chinese medicine composition for treating scrofula comprises the following components in parts by weight: 8 parts of Yuan cun; 7 parts of rhizoma sparganii; 12 parts of curcuma zedoary; 7 parts of dragon's blood; 12 parts of goose feathers.
A Chinese medicinal composition for treating scrofula is prepared into a pharmaceutically acceptable preparation by extracting and mixing; the preparation of the traditional Chinese medicine composition is a pharmaceutical preparation formed by mixing the traditional Chinese medicine composition with other pharmaceutically acceptable drug carriers or excipients, and the dosage form is the following dosage form in pharmaceutics: comprises tablet, capsule, soft capsule, granule, pill, powder, unguent, suspension, oral liquid, and injection.
A Chinese medicinal composition for treating scrofula, wherein the effective components of the Chinese medicinal composition are extracted to obtain a mixture, and the mixture is prepared into a pharmaceutically acceptable preparation; the preparation of the traditional Chinese medicine composition is a pharmaceutical preparation formed by mixing the extract of the traditional Chinese medicine composition with other pharmaceutically acceptable drug carriers or excipients, and the dosage form is the following dosage forms in pharmaceutics: comprises tablet, capsule, soft capsule, granule, pill, powder, unguent, suspension, oral liquid, and injection.
A traditional Chinese medicine composition for treating scrofula further comprises the following components in parts by weight: 1-20 parts of ginseng.
A traditional Chinese medicine composition for treating scrofula comprises the following components in parts by weight: 7 parts of Yuan cun; 6 parts of rhizoma sparganii; 13 parts of curcuma zedoary; 6 parts of dragon's blood; 13 parts of goose feathers. 11 parts of ginseng.
The invention has the beneficial effects that: the traditional Chinese medicine composition for treating scrofula provided by the invention does not generate any toxic or side effect on a human body, is safe and effective, is prepared by selecting multiple medicinal materials for combination, and generates a synergistic effect on the effects of the medicinal materials, so that the scrofula can be effectively treated, and in addition, the breast cancer, lobular hyperplasia of mammary glands, ovarian abscess and cervical lymphoid tuberculosis can be effectively treated.
For a better understanding of the features and technical content of the present invention, refer to the following detailed description of the invention.
Detailed Description
To further illustrate the technical means adopted by the present invention and the effects thereof, the following detailed description is given with reference to the preferred embodiments of the present invention.
A traditional Chinese medicine composition for treating scrofula comprises the following components in parts by weight: 5-10 parts of Yuan cun; 5-10 parts of rhizoma sparganii; 10-15 parts of curcuma zedoary; 4-9 parts of dragon's blood; 10-15 parts of goose feathers.
Example 1:
a traditional Chinese medicine composition for treating scrofula comprises the following components in parts by weight: 5 parts of Yuan cun; 10 parts of rhizoma sparganii; 10 parts of curcuma zedoary; 4 parts of dragon's blood; 10 parts of goose feathers.
Example 2:
a traditional Chinese medicine composition for treating scrofula comprises the following components in parts by weight: 10 portions of Yuancun; 10 parts of rhizoma sparganii; 15 parts of curcuma zedoary; 4 parts of dragon's blood; 15 parts of goose feathers.
Example 3:
a traditional Chinese medicine composition for treating scrofula comprises the following components in parts by weight: 8 parts of Yuan cun; 7 parts of rhizoma sparganii; 12 parts of curcuma zedoary; 7 parts of dragon's blood; 12 parts of goose feathers.
Example 5:
a traditional Chinese medicine composition for treating scrofula further comprises the following components in parts by weight: 5-10 parts of Yuan cun; 5-10 parts of rhizoma sparganii; 10-15 parts of curcuma zedoary; 4-9 parts of dragon's blood; 10-15 parts of goose feathers; 1-20 parts of ginseng.
Example 6:
a traditional Chinese medicine composition for treating scrofula comprises the following components in parts by weight: 7 parts of Yuan cun; 6 parts of rhizoma sparganii; 13 parts of curcuma zedoary; 6 parts of dragon's blood; 13 parts of goose feathers. 11 parts of ginseng.
A Chinese medicinal composition for treating scrofula is prepared into a pharmaceutically acceptable preparation by extracting and mixing; the preparation of the traditional Chinese medicine composition is a pharmaceutical preparation formed by mixing the traditional Chinese medicine composition with other pharmaceutically acceptable drug carriers or excipients, and the dosage form is the following dosage form in pharmaceutics: comprises tablet, capsule, soft capsule, granule, pill, powder, unguent, suspension, oral liquid, and injection.
A Chinese medicinal composition for treating scrofula, wherein the effective components of the Chinese medicinal composition are extracted to obtain a mixture, and the mixture is prepared into a pharmaceutically acceptable preparation; the preparation of the traditional Chinese medicine composition is a pharmaceutical preparation formed by mixing the extract of the traditional Chinese medicine composition with other pharmaceutically acceptable drug carriers or excipients, and the dosage form is the following dosage forms in pharmaceutics: comprises tablet, capsule, soft capsule, granule, pill, powder, unguent, suspension, oral liquid, and injection.
A Chinese medicinal composition for treating scrofula can be prepared into a Chinese medicinal preparation capable of regulating immune system by selecting and adding appropriate pharmaceutically acceptable auxiliary materials, and the method can be any conventional Chinese medicinal preparation production method and any conventional dosage form. The formulation is preferably an oral dosage form, more preferably a powder, capsule, tablet, most preferably a tablet, in view of patient compliance and efficacy.
Typical cases are as follows:
summer, female, 44 years old, Beijing. The local hospital can determine that the tuberculosis is scrofula, and the treatment is still mild and severe for two months without obvious improvement. The scrofula is diagnosed by the traditional Chinese medicine, the body temperature tends to be normal after two treatment courses of taking the traditional Chinese medicine composition prepared in the embodiment 3 of the invention, and then the patient is cured after continuing to take the traditional Chinese medicine composition for 2 treatment courses.
The above description is only for the specific embodiments of the present invention, but the scope of the present invention is not limited thereto, and any person skilled in the art can easily conceive of the changes or substitutions within the technical scope of the present invention, and all the changes or substitutions should be covered within the scope of the present invention. Therefore, the protection scope of the present invention shall be subject to the protection scope of the claims.

Claims (8)

1. The traditional Chinese medicine composition for treating scrofula is characterized by comprising the following components in parts by weight: 5-10 parts of Yuan cun; 5-10 parts of rhizoma sparganii; 10-15 parts of curcuma zedoary; 4-9 parts of dragon's blood; 10-15 parts of goose feathers.
2. The traditional Chinese medicine composition for treating scrofula according to claim 1, which is characterized by comprising the following components in parts by weight: 5 parts of Yuan cun; 10 parts of rhizoma sparganii; 10 parts of curcuma zedoary; 4 parts of dragon's blood; 10 parts of goose feathers.
3. The traditional Chinese medicine composition for treating scrofula according to claim 1, which is characterized by comprising the following components in parts by weight: 10 portions of Yuancun; 10 parts of rhizoma sparganii; 15 parts of curcuma zedoary; 4 parts of dragon's blood; 15 parts of goose feathers.
4. The traditional Chinese medicine composition for treating scrofula according to claim 1, which is characterized by comprising the following components in parts by weight: 8 parts of Yuan cun; 7 parts of rhizoma sparganii; 12 parts of curcuma zedoary; 7 parts of dragon's blood; 12 parts of goose feathers.
5. The traditional Chinese medicine composition for treating scrofula according to claim 1, wherein the traditional Chinese medicine composition is prepared into a pharmaceutically acceptable preparation by extraction and mixing; the preparation of the traditional Chinese medicine composition is a pharmaceutical preparation formed by mixing the traditional Chinese medicine composition with other pharmaceutically acceptable drug carriers or excipients, and the dosage form is the following dosage form in pharmaceutics: comprises tablet, capsule, soft capsule, granule, pill, powder, unguent, suspension, oral liquid, and injection.
6. The traditional Chinese medicine composition for treating scrofula according to claim 1, wherein the effective ingredients of the traditional Chinese medicine composition are prepared into a pharmaceutically acceptable preparation through extracting a mixture; the preparation of the traditional Chinese medicine composition is a pharmaceutical preparation formed by mixing the extract of the traditional Chinese medicine composition with other pharmaceutically acceptable drug carriers or excipients, and the dosage form is the following dosage forms in pharmaceutics: comprises tablet, capsule, soft capsule, granule, pill, powder, unguent, suspension, oral liquid, and injection.
7. The traditional Chinese medicine composition for treating scrofula according to claim 1, further comprising the following components in parts by weight: 1-20 parts of ginseng.
8. The traditional Chinese medicine composition for treating scrofula according to claim 7, which is characterized by comprising the following components in parts by weight: 7 parts of Yuan cun; 6 parts of rhizoma sparganii; 13 parts of curcuma zedoary; 6 parts of dragon's blood; 13 parts of goose feathers; 11 parts of ginseng.
CN202110628752.2A 2021-06-04 2021-06-04 Traditional Chinese medicine composition for treating scrofula Pending CN113197993A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110628752.2A CN113197993A (en) 2021-06-04 2021-06-04 Traditional Chinese medicine composition for treating scrofula

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110628752.2A CN113197993A (en) 2021-06-04 2021-06-04 Traditional Chinese medicine composition for treating scrofula

Publications (1)

Publication Number Publication Date
CN113197993A true CN113197993A (en) 2021-08-03

Family

ID=77024006

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110628752.2A Pending CN113197993A (en) 2021-06-04 2021-06-04 Traditional Chinese medicine composition for treating scrofula

Country Status (1)

Country Link
CN (1) CN113197993A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1220891A (en) * 1998-10-29 1999-06-30 刘喜斌 Formula of large plaster for treating breast furuncle scrofula, prolapse of lumbar intervertebral disc and making method thereof
CN1231920A (en) * 1999-03-25 1999-10-20 韩振标 Formulation of medicine for treating scrofula, and its preparing process
CN1312112A (en) * 2001-03-02 2001-09-12 吴振刚 Cure-all ointment

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1220891A (en) * 1998-10-29 1999-06-30 刘喜斌 Formula of large plaster for treating breast furuncle scrofula, prolapse of lumbar intervertebral disc and making method thereof
CN1231920A (en) * 1999-03-25 1999-10-20 韩振标 Formulation of medicine for treating scrofula, and its preparing process
CN1312112A (en) * 2001-03-02 2001-09-12 吴振刚 Cure-all ointment

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
张晓兵: "消瘰汤治疗瘰疬99例疗效观察", 《河南中医学院学报》 *

Similar Documents

Publication Publication Date Title
US6841544B2 (en) Composition and method for treating the effects of diseases and maladies
US6787164B2 (en) Composition and method for treating the effects of diseases and maladies
US20020128273A1 (en) Composition and method for treating the effects of diseases and maladies
CN103768308A (en) Medicament composition for treating upper respiratory infections and preparation method thereof
CN110548077B (en) Pharmaceutical composition for treating chronic pharyngitis and preparation method and application thereof
CN104983844A (en) Edible composition formula with mucous-membrane restoring function and preparation process of preparation thereof
CN102106965B (en) Composition for treating acute injury of soft tissue and application thereof
CN101396528B (en) Traditional Chinese medicine composite preparation for treating wind-heat cold
CN101209263B (en) Medicine for treating tumor
CN109453169B (en) Application of bulleyaconitine A
US20020034555A1 (en) Composition and method for treating the effects of diseases and maladies
CN105535406A (en) Traditional Chinese medicine composition for preventing and treating livestock respiratory disease
CN102240345A (en) Compound Chinese herbal medicine preparation for preventing and treating Newcastle disease
CN113197993A (en) Traditional Chinese medicine composition for treating scrofula
CN104274682A (en) Traditional Chinese medicine composition for treating coal workers' pneumoconiosis and preparation method of traditional Chinese medicine composition
CN102614365B (en) Traditional Chinese medical composition for treatment of breast tumor
CN112168947A (en) Traditional Chinese medicine composition for treating pneumonia and preparation method thereof
CN107233481B (en) A kind of Chinese medicine composition to invigorate the kidney and stop nocturnal emission, medicinal liquor and its preparation method and application
CN106361829B (en) Traditional Chinese medicine composition and preparation for treating ischemic stroke and preparation method thereof
CN105853766A (en) Purpose of traditional Chinese medicinal preparation for preparing medicine for treating primary hypertension
US20010043959A1 (en) Composition and method for treating the effects of diseases and maladies
CN113209244A (en) Traditional Chinese medicine composition for treating pancreatic cancer
CN109999143B (en) Traditional Chinese medicine for treating benign tumor proliferative diseases
CN104367620B (en) A kind of Chinese medicine composition for preventing pharyngitis and preparation method thereof
CN106924679A (en) A kind of medicine for treating gastric ulcer

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20210803